Author:
Ouwerkerk-Mahadevan Sivi,Snoeys Jan,Peeters Monika,Beumont-Mauviel Maria,Simion Alexandru
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference52 articles.
1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52.
2. Ghany MG, Nelson DR, Strader DB, et al. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(4):1433–44.
3. American Association for the Study of Liver Diseases, Infectious Diseases Society of America, International Antiviral Society—USA. Recommendations for testing, managing, and treating hepatitis C [online]. http://www.hcvguidelines.org . Published 21 March 2014. Accessed 20 Aug 2014.
4. Jacobson IM, Dore GJ, Foster GR, et al. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2014;384(9941):403–13.
5. European Medicines Agency. OLYSIO 150 mg hard capsules: summary of product characteristics [online]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002777/WC500167869.pdf . Published 06 Apr 2014. Accessed 30 Jun 2014.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献